KEGG   PATHWAY: ocu04071
Entry
ocu04071                    Pathway                                
Name
Sphingolipid signaling pathway - Oryctolagus cuniculus (rabbit)
Description
Sphingomyelin (SM) and its metabolic products are now known to have second messenger functions in a variety of cellular signaling pathways. Particularly, the sphingolipid metabolites, ceramide (Cer) and sphingosine-1-phosphate (S1P), have emerged as a new class of potent bioactive molecules. Ceramide can be generated de novo or by hydrolysis of membrane sphingomyelin by sphingomyelinase (SMase). Ceramide is subsequently metabolized by ceramidase to generate sphingosine (Sph) which in turn produces S1P through phosphorylation by sphingosine kinases 1 and 2 (SphK1, 2). Both ceramide and S1P regulate cellular responses to stress, with generally opposing effects. S1P functions as a growth and survival factor, acting as a ligand for a family of G protein-coupled receptors, whereas ceramide activates intrinsic and extrinsic apoptotic pathways through receptor-independent mechanisms.
Class
Environmental Information Processing; Signal transduction
Pathway map
ocu04071  Sphingolipid signaling pathway
ocu04071

Organism
Oryctolagus cuniculus (rabbit) [GN:ocu]
Gene
100008725  ADORA3; adenosine receptor A3 [KO:K04268]
100008820  S1PR1; sphingosine 1-phosphate receptor 1 [KO:K04288]
100008828  S1PR2; sphingosine 1-phosphate receptor 2 [KO:K04292]
100009088  TNF; tumor necrosis factor precursor [KO:K03156]
100009102  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
100009103  PRKCE; protein kinase C epsilon type [KO:K18050] [EC:2.7.11.13]
100009139  PPP2R2B; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform [KO:K04354]
100009215  PPP2R5B; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform [KO:K11584]
100009216  PPP2R5C; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform [KO:K11584]
100009220  ROCK1; rho-associated protein kinase 1 [KO:K04514] [EC:2.7.11.39]
100009252  PPP2CA; serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [KO:K04382] [EC:3.1.3.16]
100009292  TP53; cellular tumor antigen p53 [KO:K04451]
100009300  PPP2CB; serine/threonine-protein phosphatase 2A catalytic subunit beta isoform [KO:K04382] [EC:3.1.3.16]
100009316  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100009434  [KO:K11584]
100009498  NOS3; nitric oxide synthase, endothelial [KO:K13242] [EC:1.14.13.39]
100009533  PPP2R5D; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform [KO:K11584]
100009538  PRKCZ; protein kinase C zeta type [KO:K18952] [EC:2.7.11.13]
100037719  PRKCB; protein kinase C beta type isoform I [KO:K19662] [EC:2.7.11.13]
100037720  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
100101602  [KO:K03898]
100328615  ADORA1; adenosine receptor A1 [KO:K04265]
100328616  PPP2R2A; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform [KO:K04354]
100328617  PPP2R2C; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform [KO:K04354]
100337822  [KO:K00922] [EC:2.7.1.153]
100337851  [KO:K24622]
100337862  [KO:K01441] [EC:3.5.1.23]
100337888  [KO:K03171]
100337999  [KO:K04440] [EC:2.7.11.24]
100338130  [KO:K18953]
100338209  [KO:K12348] [EC:3.5.1.23]
100338261  [KO:K26384]
100338359  [KO:K03916]
100338391  [KO:K04630]
100338930  [KO:K01634] [EC:4.1.2.27]
100339066  [KO:K04630]
100339302  [KO:K00654] [EC:2.3.1.50]
100339661  [KO:K01115] [EC:3.1.4.4]
100339741  [KO:K05703] [EC:2.7.10.2]
100339873  [KO:K04392]
100339974  [KO:K23727]
100340498  [KO:K04426] [EC:2.7.11.25]
100340661  [KO:K04513]
100340719  [KO:K04634]
100341512  [KO:K05858] [EC:3.1.4.11]
100341695  [KO:K04441] [EC:2.7.11.24]
100342664  [KO:K04440] [EC:2.7.11.24]
100342852  [KO:K04456] [EC:2.7.11.1]
100343368  [KO:K04513]
100343680  [KO:K04513]
100344161  [KO:K04441] [EC:2.7.11.24]
100344241  [KO:K07828]
100344536  [KO:K00654] [EC:2.3.1.50]
100344726  [KO:K23727]
100345181  [KO:K00922] [EC:2.7.1.153]
100345221  [KO:K04712] [EC:1.14.19.17 1.14.18.5]
100345250  [KO:K02649]
100345841  ABCC1; multidrug resistance-associated protein 1 isoform X1 [KO:K05665] [EC:7.6.2.3]
100346106  [KO:K03158]
100346837  [KO:K17388] [EC:2.7.11.39]
100346856  [KO:K04513]
100346929  [KO:K04440] [EC:2.7.11.24]
100346997  [KO:K11584]
100347293  [KO:K04346]
100347345  [KO:K04371] [EC:2.7.11.24]
100347407  [KO:K04366] [EC:2.7.11.1]
100347487  [KO:K07827]
100347954  [KO:K06276] [EC:2.7.11.1]
100348153  [KO:K12351] [EC:3.1.4.12]
100348286  [KO:K04354]
100348561  [KO:K04371] [EC:2.7.11.24]
100348663  [KO:K00922] [EC:2.7.1.153]
100348672  [KO:K05858] [EC:3.1.4.11]
100348967  [KO:K04513]
100349301  [KO:K08091]
100349426  [KO:K02580]
100349846  [KO:K08089]
100350217  [KO:K04295]
100350395  [KO:K05858] [EC:3.1.4.11]
100350614  [KO:K04441] [EC:2.7.11.24]
100351268  [KO:K04213]
100351385  [KO:K08090]
100352794  [KO:K04639]
100352973  [KO:K24621]
100353545  [KO:K11583]
100353706  [KO:K04456] [EC:2.7.11.1]
100353898  [KO:K12350] [EC:3.1.4.12]
100354454  [KO:K04714] [EC:2.7.8.27 3.1.4.62]
100355061  [KO:K26384]
100355092  [KO:K03456]
100355159  [KO:K11583]
100355393  [KO:K04712] [EC:1.14.19.17 1.14.18.5]
100355675  [KO:K02159]
100355758  [KO:K03456]
100355991  [KO:K04726]
100356250  [KO:K04513]
100356520  [KO:K07860]
100356580  [KO:K11583]
100357673  [KO:K12349] [EC:3.5.1.23]
100357790  [KO:K04718] [EC:2.7.1.91]
100357833  [KO:K04717] [EC:3.1.3.-]
100357841  [KO:K02649]
100357932  [KO:K04714] [EC:2.7.8.27 3.1.4.62]
100358555  [KO:K00654] [EC:2.3.1.50]
100358716  [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
100359147  [KO:K04630]
103346035  [KO:K04441] [EC:2.7.11.24]
103346370  [KO:K04718] [EC:2.7.1.91]
103347536  [KO:K05858] [EC:3.1.4.11]
103348690  [KO:K04290]
103349397  [KO:K02161]
103350027  [KO:K07983]
103351479  [KO:K01115] [EC:3.1.4.4]
108178643  [KO:K04716] [EC:3.1.3.-]
127485184  [KO:K04735]
127485960  [KO:K04710] [EC:2.3.1.299]
127486116  [KO:K04456] [EC:2.7.11.1]
127486605  [KO:K02833]
127489236  [KO:K07827]
127489461  [KO:K04368] [EC:2.7.12.2]
127489660  [KO:K04513]
127493711  [KO:K13242] [EC:1.14.13.39]
Compound
C00065  L-Serine
C00154  Palmitoyl-CoA
C00165  Diacylglycerol
C00195  N-Acylsphingosine
C00212  Adenosine
C00319  Sphingosine
C00346  Ethanolamine phosphate
C00533  Nitric oxide
C00550  Sphingomyelin
C00836  Sphinganine
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C06124  Sphingosine 1-phosphate
C12126  Dihydroceramide
C16845  Peroxynitrite
Reference
  Authors
Hannun YA, Obeid LM
  Title
Principles of bioactive lipid signalling: lessons from sphingolipids.
  Journal
Nat Rev Mol Cell Biol 9:139-50 (2008)
DOI:10.1038/nrm2329
Reference
  Authors
Taha TA, Mullen TD, Obeid LM
  Title
A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.
  Journal
Biochim Biophys Acta 1758:2027-36 (2006)
DOI:10.1016/j.bbamem.2006.10.018
Reference
  Authors
Liu J, Beckman BS, Foroozesh M
  Title
A review of ceramide analogs as potential anticancer agents.
  Journal
Future Med Chem 5:1405-21 (2013)
DOI:10.4155/fmc.13.107
Reference
  Authors
Kono M, Allende ML, Proia RL
  Title
Sphingosine-1-phosphate regulation of mammalian development.
  Journal
Biochim Biophys Acta 1781:435-41 (2008)
DOI:10.1016/j.bbalip.2008.07.001
Reference
  Authors
Olivera A
  Title
Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model.
  Journal
Prostaglandins Other Lipid Mediat 86:1-11 (2008)
DOI:10.1016/j.prostaglandins.2008.02.005
Reference
  Authors
Brunkhorst R, Vutukuri R, Pfeilschifter W
  Title
Fingolimod for the treatment of neurological diseases-state of play and future perspectives.
  Journal
Front Cell Neurosci 8:283 (2014)
DOI:10.3389/fncel.2014.00283
Reference
  Authors
Rosen H, Goetzl EJ
  Title
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.
  Journal
Nat Rev Immunol 5:560-70 (2005)
DOI:10.1038/nri1650
Reference
  Authors
Pyne S, Pyne NJ
  Title
Sphingosine 1-phosphate signalling in mammalian cells.
  Journal
Biochem J 349:385-402 (2000)
DOI:10.1042/bj3490385
Reference
  Authors
Egom EE, Mohamed TM, Mamas MA, Shi Y, Liu W, Chirico D, Stringer SE, Ke Y, Shaheen M, Wang T, Chacko S, Wang X, Solaro RJ, Fath-Ordoubadi F, Cartwright EJ, Lei M
  Title
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
  Journal
Am J Physiol Heart Circ Physiol 301:H1487-95 (2011)
DOI:10.1152/ajpheart.01003.2010
Reference
  Authors
Jin ZQ, Goetzl EJ, Karliner JS
  Title
Sphingosine kinase activation mediates ischemic preconditioning in murine heart.
  Journal
Circulation 110:1980-9 (2004)
DOI:10.1161/01.CIR.0000143632.06471.93
Reference
  Authors
Melendez AJ
  Title
Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.
  Journal
Biochim Biophys Acta 1784:66-75 (2008)
DOI:10.1016/j.bbapap.2007.07.013
Reference
  Authors
Halova I, Draberova L, Draber P
  Title
Mast cell chemotaxis - chemoattractants and signaling pathways.
  Journal
Front Immunol 3:119 (2012)
DOI:10.3389/fimmu.2012.00119
Reference
  Authors
Kraft S, Kinet JP
  Title
New developments in FcepsilonRI regulation, function and inhibition.
  Journal
Nat Rev Immunol 7:365-78 (2007)
DOI:10.1038/nri2072
Reference
  Authors
Gilfillan AM, Tkaczyk C.
  Title
Integrated signalling pathways for mast-cell activation.
  Journal
Nat Rev Immunol 6:218-30 (2006)
DOI:10.1038/nri1782
Reference
  Authors
Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, Nakashima S, Moriwaki H
  Title
TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.
  Journal
J Immunol 167:173-80 (2001)
DOI:10.4049/jimmunol.167.1.173
Reference
  Authors
Montfort A, Martin PG, Levade T, Benoist H, Segui B
  Title
FAN (factor associated with neutral sphingomyelinase activation), a moonlighting protein in TNF-R1 signaling.
  Journal
J Leukoc Biol 88:897-903 (2010)
DOI:10.1189/jlb.0410188
Reference
  Authors
Chatterjee S
  Title
Neutral sphingomyelinase: past, present and future.
  Journal
Chem Phys Lipids 102:79-96 (1999)
DOI:10.1016/S0009-3084(99)00077-8
Related
pathway
ocu00600  Sphingolipid metabolism
ocu04010  MAPK signaling pathway
ocu04142  Lysosome
ocu04151  PI3K-Akt signaling pathway
KO pathway
ko04071   

DBGET integrated database retrieval system